U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1248112481MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary LesionsRecruitingNo Results AvailableCoronary Artery DiseaseDevice: MAGIC-TOUCH Drug-eluting Balloonhttps://ClinicalTrials.gov/show/NCT02400632
1248212482Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Crossover RCTRecruitingNo Results AvailableSpasticity|Cerebral PalsyDevice: shock waves|Drug: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT02400619
1248312483The Effect of Constructing Virtual Patient CasesCompletedNo Results AvailableHealthyOther: Constructing VP cases|Other: Solving VP caseshttps://ClinicalTrials.gov/show/NCT02400606
1248412484Health Experiences & Early Life DisadvantagesNot yet recruitingNo Results AvailableSusceptibility to Illness|Early Life Adversity|Chronic StressBehavioral: Meditation Workshophttps://ClinicalTrials.gov/show/NCT02400593
1248512485IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic HysterectomyRecruitingNo Results AvailablePainDrug: IV acetaminophen|Drug: placebohttps://ClinicalTrials.gov/show/NCT02400580
1248612486Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal WomenRecruitingNo Results AvailableNeoadjuvant Operable Breast CancerDrug: Fluorouracile|Drug: Epirubicin|Drug: Cyclophosphamide|Drug: Letrozole|Drug: Palbociclibhttps://ClinicalTrials.gov/show/NCT02400567
1248712487Yappalli - The Road to Choctaw HealthRecruitingNo Results AvailableObesity|Substance AbuseBehavioral: Yappallihttps://ClinicalTrials.gov/show/NCT02400554
1248812488Efficacity of Cognitive Remediation Treatment Compared to a Controlled Group in Young Patient With Anorexia NervosaRecruitingNo Results AvailableAnorexia NervosaBehavioral: Cognitive remediation therapy|Other: relaxation therapyhttps://ClinicalTrials.gov/show/NCT02400541
1248912489Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their FamiliesRecruitingNo Results AvailableParaparesis|Tetraparesis|Hemiparesis|Ataxia|Neuromuscular Disorders|Extrapyramidal Motor DisordersBehavioral: quality of life questionnaireshttps://ClinicalTrials.gov/show/NCT02400528
1249012490Influence of Regular Exercise and Detraining on Metabolic and Emotional Parameters in Diabetic IndividualsCompletedNo Results AvailableDiabetes Mellitus, Type 2Other: Exercisehttps://ClinicalTrials.gov/show/NCT02400515
1249112491Integrated Coping and Awareness TrainingActive, not recruitingNo Results AvailableSchizophreniaBehavioral: I-CAT Therapyhttps://ClinicalTrials.gov/show/NCT02400502
1249212492Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese PatientsRecruitingNo Results AvailableMitral Valve or Aortic Valve Replacementhttps://ClinicalTrials.gov/show/NCT02400489
1249312493A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and LoperamideRecruitingNo Results AvailableEarly Stage HER2+ Breast CancerDrug: Neratinib|Drug: Loperamidehttps://ClinicalTrials.gov/show/NCT02400476
1249412494A Pilot Study of Ruxolitinib in Secondary Hemophagocytic SyndromeNot yet recruitingNo Results AvailableHemophagocytic Syndrome (HPS)Drug: Ruxolitinibhttps://ClinicalTrials.gov/show/NCT02400463
1249512495Designer Functional Foods on Parameters of Metabolic and Vascular in PrediabetesNot yet recruitingNo Results AvailablePre-DiabetesDietary Supplement: Functional Ingredient Group|Dietary Supplement: Control Ingredient Grouphttps://ClinicalTrials.gov/show/NCT02400450
1249612496Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's MacroglobulinemiaRecruitingNo Results AvailableWaldenstrom's MacroglobulinemiaDrug: Ixazomib|Drug: Dexamethasone|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT02400437
1249712497Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorActive, not recruitingNo Results AvailableNon-small-cell Lung CarcinomaRadiation: SBRThttps://ClinicalTrials.gov/show/NCT02400424
1249812498The Glycemic and Insulinemic Responses Elicited by Meals Containing Whole Grain Rye Bread or White Wheat BreadActive, not recruitingNo Results AvailableBlood Glucose ConcentrationOther: Wheat bread|Other: margarine|Other: ham|Other: soup|Other: rye breadhttps://ClinicalTrials.gov/show/NCT02400411
1249912499Treatment for Pancreatic Cancer CachexiaRecruitingNo Results AvailablePancreatic Neoplasms|Advanced Pancreatic Cancer|Cachexia|Weight LossDrug: Peptamenhttps://ClinicalTrials.gov/show/NCT02400398
1250012500A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced MelanomaRecruitingNo Results AvailableMelanomaDrug: sunitinib|Drug: nivolumabhttps://ClinicalTrials.gov/show/NCT02400385
1250112501The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor SiteNot yet recruitingNo Results AvailableDisorder of Skin Donor SiteDevice: medihoney dressinghttps://ClinicalTrials.gov/show/NCT02400372
1250212502Lorcaserin in Obesity: Identification of CNS Targets Using fMRIActive, not recruitingNo Results AvailableObesity|Weight LossDrug: Lorcaserin HCl|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02400359
1250312503Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant TreatmentRecruitingNo Results AvailableMajor Depression DisorderDrug: Adjunct brexpiprazolehttps://ClinicalTrials.gov/show/NCT02400346
1250412504Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR TabletCompletedNo Results AvailableBioavailability|Healthy SubjectsDrug: Ticagrelor OD tablet (90 mg single dose) administered with 200 ml of water|Drug: Ticagrelor OD tablet (90 mg single dose) administered without water|Drug: Ticagrelor OD tablet (90 mg single dose) suspended in water administered via nasogastric tube|Drug: Brilique®, Ticagrelor IR tablet (90 mg) administered with 200mL of waterhttps://ClinicalTrials.gov/show/NCT02400333
1250512505Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate and MentholNot yet recruitingNo Results AvailableSkin IrritationDrug: Topical Spray|Drug: Topical Gel|Other: Salinehttps://ClinicalTrials.gov/show/NCT02400320
1250612506Pharmacokinetics of GS-9883 in Adults With Normal and Impaired Renal FunctionCompletedNo Results AvailableHIVDrug: GS-9883https://ClinicalTrials.gov/show/NCT02400307
1250712507Prevention of Ventilator Associated Pneumonia With Toothbrushing in Oral Care of Critically Ill Mechanically Ventilated PatientsRecruitingNo Results AvailableCritical Care|Mechanical Ventilation|Ventilator Associated Pneumonia Prevention|Toothbrushing|Oral CareOther: Toothbrushinghttps://ClinicalTrials.gov/show/NCT02400294
1250812508Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia PatientsNot yet recruitingNo Results AvailableAcute Myeloid LeukemiaDrug: crenolanib besylate|Drug: idarubicin|Drug: cytarabine|Drug: azacytidinehttps://ClinicalTrials.gov/show/NCT02400281
1250912509Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by EnterobacteriaceaeRecruitingNo Results AvailableEnterobacteriaceae Infections|Bloodstream InfectionOther: 7 days course of antibiotic treatment|Other: 14 days course of antibiotic treatmenthttps://ClinicalTrials.gov/show/NCT02400268
1251012510Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia PatientsNot yet recruitingNo Results AvailableAcute Myeloid LeukemiaDrug: crenolanib besylatehttps://ClinicalTrials.gov/show/NCT02400255

* Görseller ve İçerik tekif hakkına sahip olabilir